We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > enalapril

News List

Novartis says Entresto outperforms heart failure drug enalapril in key study firstwordpharma
November 13, 2018
Novartis presented study data at the American Heart Association's (AHA) scientific sessions showing that Entresto (sacubitril/valsartan) outperformed enalapril in patients with heart failure with reduced ejection fraction requiring hospitalisation for an
Novartis says Entresto outperforms heart failure drug enalapril in key study firstwordpharma
November 13, 2018
Novartis presented study data at the American Heart Association's (AHA) scientific sessions showing that Entresto (sacubitril/valsartan) outperformed enalapril in patients with heart failure with reduced ejection fraction requiring hospitalisation for an